Oct 12, 2022 8:15am EDT bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference
Sep 28, 2022 8:15am EDT bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M
Sep 14, 2022 8:15am EDT bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE
Sep 06, 2022 11:28am EDT bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering
Dec 06, 2021 11:00am EST bioAffinity Technologies Presents its Cancer Therapeutic Research at Joint ASCB-EMBO Meeting
Oct 14, 2021 11:00am EDT bioAffinity Technologies Announces Xavier T. Reveles Promoted to Vice President of Operations
Sep 23, 2021 11:00am EDT bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer
Sep 14, 2021 11:00am EDT bioAffinity Technologies Announces Precision Pathology Services’ Validation of Novel Non-Invasive Early Lung Cancer Test
Aug 12, 2021 11:00am EDT bioAffinity Technologies Publishes Sputum Processing and Innovative High-Throughput Analysis Methods
